Clinical Trial Update: A Pivotal Study of N-Acetyl-L-Leucine on Ataxia-Telangiectasia (A-T) [Phase 3]

View source ↗

Summary

A pivotal Phase 3 study evaluating N-Acetyl-L-Leucine for Ataxia-Telangiectasia is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ataxia-telangiectasia

Drugs mentioned

• N-Acetyl-L-Leucine (N-acetyl-L-leucine)

Snippet

Sponsor: IntraBio Inc | Conditions: Ataxia-Telangiectasia, Ataxia-Telangiectasia (A-T) | Phase 3 | Status: ACTIVE_NOT_RECRUITING